Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension.

Arthritis Res Ther · 2017 · PMC5457656 · PMID 28576149

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendp = 0.10so close (0.05 < p ≤ 0.1)

Additionally, PAH combination therapy (all cases were a combination of a PDE5 inhibitor and an ERA) also showed a trend towards a survival benefit compared with monotherapy alone ( p = 0.10).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.